{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:26:43Z","timestamp":1793050003179,"version":"4.5.0"},"reference-count":55,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000199","name":"U.S. Department of Agriculture","doi-asserted-by":"publisher","award":["USDA-APHIS-10025-OA000000-23-0001"],"award-info":[{"award-number":["USDA-APHIS-10025-OA000000-23-0001"]}],"id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2026,6,23]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>The continued evolution of SARS-CoV-2 has yielded highly immune-evasive Omicron subvariants that challenge existing population immunity. In late 2024, a novel subvariant designated BA.3.2 emerged independently from the BA.3 lineage, carrying over 50 spike mutations, and representing a distinct evolutionary branch with unclear biological properties. Here, we characterize the BA.3.2 spike-mediated entry, fusogenicity, antigenicity, and neutralization in comparison to its parental BA.3- and JN.1-derived co-circulating LP.8.1 subvariants. Using lentiviral pseudotyping assays, we show that BA.3.2 exhibits significantly reduced infectivity in both 293T-ACE2 and CaLu-3 cells relative to BA.3, accompanied by attenuated spike-mediated cell\u2013cell fusion. Despite its impaired entry, BA.3.2 evades neutralizing antibodies (nAbs) elicited by bivalent mRNA vaccination, Omicron BA.1-wave, and JN.1-wave infection, with a &gt; 25-fold reduction in nAb titers compared to BA.3 in both bivalent mRNA vaccination and Omicron BA.1-wave cohorts. Antigenic mapping confirms remarkable divergences of BA.3.2 and LP.8.1 from the ancestral D614G, Omicron BA.3, and JN.1. Mechanistically, BA.3.2 acquires four new N-linked glycosylation sites in the N-terminal domain (NTD) and receptor-binding domain (RBD) of spike; disruption of which enhances viral infectivity and restores sensitivity to nAbs, suggesting a functional trade-off between immune evasion and spike functionality. Together, our findings define BA.3.2 as a highly immune-evasive variant with altered spike properties, shaped in part by glycan alteration. These results underscore the ongoing antigenic diversification of SARS-CoV-2 and highlight the importance of monitoring independent evolutionary trajectories outside the dominant JN.1 lineage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>IMPORTANCE<\/jats:title>\n                    <jats:p>The Omicron subvariant BA.3.2 has independently evolved from an early BA.3 lineage, carrying over 50 amino acid substitutions in its spike protein. Our study demonstrates that BA.3.2 exhibits markedly reduced infectivity and fusion activity but strong resistance to neutralizing antibodies elicited by vaccination or prior Omicron infection. We further show that newly acquired N-linked glycans in both the N-terminal and receptor-binding domains of BA.3.2 contribute to immune escape, while impairing spike-mediated entry. These findings reveal that glycan remodeling represents a key mechanism driving SARS-CoV-2 antigenic diversification and functional trade-offs between immune evasion and infectivity. Monitoring such independently evolving Omicron lineages is essential for understanding ongoing viral adaptation and for guiding future vaccine design.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/jvi.00016-26","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:03:23Z","timestamp":1778591003000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":3,"title":["Altered infectivity, cell-cell fusion, and immune evasion of SARS-CoV-2 BA.3.2 and LP.8.1 variants"],"prefix":"10.1128","volume":"100","author":[{"given":"Pei","family":"Li","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00rs6vg23","id-type":"ROR","asserted-by":"publisher"}],"name":"Center for Retrovirus Research, The Ohio State University","place":["Columbus, USA"]},{"id":[{"id":"https:\/\/ror.org\/00rs6vg23","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Veterinary Biosciences, The Ohio State University","place":["Columbus, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Min","family":"Zheng","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00rs6vg23","id-type":"ROR","asserted-by":"publisher"}],"name":"Center for Retrovirus Research, The Ohio State University","place":["Columbus, USA"]},{"id":[{"id":"https:\/\/ror.org\/00rs6vg23","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Veterinary Biosciences, The Ohio State University","place":["Columbus, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1620-3817","authenticated-orcid":true,"given":"Shan-Lu","family":"Liu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00rs6vg23","id-type":"ROR","asserted-by":"publisher"}],"name":"Center for Retrovirus Research, The Ohio State University","place":["Columbus, USA"]},{"id":[{"id":"https:\/\/ror.org\/00rs6vg23","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Veterinary Biosciences, The Ohio State University","place":["Columbus, USA"]},{"id":[{"id":"https:\/\/ror.org\/00rs6vg23","id-type":"ROR","asserted-by":"publisher"}],"name":"Viruses and Emerging Pathogens Program, Infectious Diseases Institute,The Ohio State University","place":["Columbus, USA"]},{"id":[{"id":"https:\/\/ror.org\/00rs6vg23","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Microbial Infection and Immunity, The Ohio State University","place":["Columbus, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-023-01769-3"},{"key":"e_1_3_2_3_2","unstructured":"Rajnarayanan R. 2024. Global SARSCoV2 variant landscape - at a glance. Available from: https:\/\/public.tableau.com\/app\/profile\/raj.rajnarayanan\/viz\/ConvergentLineages-VariantSoup-World\/G20"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00744-2"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46490-7"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08315-x"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00751-24"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00242-25"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00464-25"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114520"},{"key":"e_1_3_2_11_2","unstructured":"CDC. 2022. COVID data tracker variant proportions"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00298-6"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00415-8"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00505-X"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115543"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115140"},{"key":"e_1_3_2_17_2","unstructured":"GISAID. 2025. EpiCoV database on global initiative on sharing all influenza data. Available from: https:\/\/gisaid.org"},{"key":"e_1_3_2_18_2","unstructured":"World Health Organization. 2025. SARS-CoV-2 variant BA.3.2: initial risk evaluation 5 December 2025. Geneva Switzerland World Health Organization. https:\/\/cdn.who.int\/media\/docs\/default-source\/documents\/epp\/tracking-sars-cov-2\/05122025_ba.3.2_ire.pdf."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/ve\/veag011"},{"key":"e_1_3_2_20_2","unstructured":"WHO. 2025. Types of data requested to inform December 2025 COVID-19 vaccine antigen composition deliberations. Available from: https:\/\/www.who.int\/activities\/tracking-SARS-CoV-2-variants"},{"key":"e_1_3_2_21_2","unstructured":"Department of Health GoWA. 2025. Respiratory virus wastewater surveillance. Available from: https:\/\/www.health.wa.gov.au\/articles\/n_r\/respiratory-virus-wastewater-surveillance"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110829"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04266-9"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00992-2"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2022.04.014"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.12.026"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00308-1"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00079-9"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00015-5"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2205019"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03176-22"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04474-x"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-021-00418-x"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.01.019"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04388-0"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04442-5"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04462-1"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.12.025"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2025.101165"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.04.035"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2024.06.012"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.08.002"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00776-x"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.72109"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.3390\/v14030532"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01175-25"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012757"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00171-23"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb9983"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.07.007"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000788"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/8.3.275"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.molbev.a040023"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msab120"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.143213"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1097211"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jvi.00016-26","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jvi.00016-26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:45:30Z","timestamp":1783514730000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/jvi.00016-26"}},"subtitle":[],"editor":[{"given":"Ryan A.","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,23]]}},"alternative-id":["10.1128\/jvi.00016-26"],"URL":"https:\/\/doi.org\/10.1128\/jvi.00016-26","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"2026-03-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00016-26"}}